Related Experiment Videos
Living-related pediatric liver transplantation
1Department of Surgery, University of Nebraska Medical Center, Omaha 68198-3280.
Insights
Living-related liver transplantation (LRLT) significantly reduces preoperative mortality in pediatric patients. This procedure allows for elective scheduling, improving survival rates for children with end-stage liver disease.
Area of Science:
- Hepatology
- Pediatric Surgery
- Transplantation Medicine
Background:
- Pediatric liver disease necessitates innovative treatment strategies.
- Living-related liver transplantation (LRLT) was developed to address high preoperative mortality in small pediatric recipients.
- Traditional deceased donor liver transplantation faces challenges in pediatric cases.
Purpose of the Study:
- To evaluate the efficacy and safety of living-related liver transplantation (LRLT) in pediatric patients.
- To demonstrate the benefits of LRLT in reducing preoperative mortality and optimizing transplant timing.
- To advocate for wider availability of LRLT for pediatric end-stage liver disease.
Main Methods:
- Application of LRLT in pediatric recipients across a wide weight range (0.3 to 50 kg).
- Analysis of recipient survival rates and donor outcomes.
- Elective scheduling of transplantation procedures.
Main Results:
- Successful LRLT performed on pediatric patients from 0.3 to 50 kg.
- Recipient survival rates exceeding 90% reported in recent series.
- Zero donor mortality or long-term complications observed.
Conclusions:
- LRLT is a safe and effective option for pediatric end-stage liver disease.
- LRLT improves survival and allows for optimal timing of liver transplantation in children.
- Experienced centers should offer LRLT to eligible pediatric patients.
Abstract:
Living-related liver transplantation (LRLT) was developed to reduce preoperative mortality in the small pediatric patient. It has now been successfully used for recipients ranging in size from 0.3 to 50 kg. Besides reducing preoperative mortality, LRLT offers the ability to electively schedule transplantation at the optimal time for the child's survival, evidenced by recent series with greater than 90% recipient survival coupled with 0% donor mortality or long-term complications. Living-related transplantation (LRT) should be made available at centers with experience to all children with end-stage liver disease.